Bausch Health Cos - Stock Split History | BHC

Stock split history for Bausch Health Cos since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Bausch Health Cos Annual Stock Splits
Bausch Health Cos Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $10.108B $8.380B
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.276B 11.17
Teva Pharmaceutical Industries (TEVA) Israel $11.292B 4.60
Mylan (MYL) United States $9.745B 4.37
Dr Reddy's Laboratories (RDY) India $6.662B 17.48
ASPEN PHARMACR (APNHY) South Africa $3.568B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.202B 11.63
Amphastar Pharmaceuticals (AMPH) United States $0.891B 46.29
Homology Medicines (FIXX) United States $0.791B 0.00
Voyager Therapeutics (VYGR) United States $0.530B 0.00
Akorn (AKRX) United States $0.487B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.433B 0.00
Assembly Biosciences (ASMB) United States $0.418B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.326B 0.44
Adamas Pharmaceuticals (ADMS) United States $0.178B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.138B 0.00
CymaBay Therapeutics (CBAY) United States $0.113B 0.00
Teligent (TLGT) United States $0.035B 0.00
China Pharma Holdings (CPHI) China $0.010B 0.00